Biotek-snakken — December 2020
-
Ved ikke om det er limket jeg sendte i Orpha men op5%
-

-
SIOX Announces Positive Six-Month Follow-Up Data from Low-Dose Cohort of Phase 1/2 Trial of AXO-AAV-GM1 for GM1 Gangliosidosis. http://www.globenewswire.com/news-release/2020/12/15/2145743/0/en/Sio-Gene-Therapies-Announces-Positive-Six-Month-Follow-Up-Data-from-Low-Dose-Cohort-of-Phase-1-2-Trial-of-AXO-AAV-GM1-for-GM1-Gangliosidosis.html SIOX stiger ca. 43% efter luk. Endelig stiger den, så nu håber jeg ikke de laver en offering
-
Godmorgen....imponerende emi kursen er helt oppe i 62 og vel fint på den lange bane, da de satser endnu mere på CAN04 og CAN10
-
Arvinas henter penge i kurs 70 https://ir.arvinas.com/news-releases/news-release-details/arvinas-inc-announces-pricing-400-million-public-offering-common
-
Div præsentationer(inklusiv Cantargia) fra DNB Healthcare conferance. Muligt den har været linket før.https://dnb-play.screen9.tv/media/ZzqauyuMwOuMeyieHTSI9A/dnb-markets-session-ii-cantargia
-
Jeg tror Scandion Oncology nok er ret stille frem mod data i mCRC i Q2. Hvis data etablerer/indikerer PoC og de forstsætter lægemiddeludviklingen og deres samarbejde med Alligator bærer frugt skal kursen nok op i mod hvad den var i sommers da det gik højest. Mht. aktierne handles de allerede, så tror ikke det influerer mere på kursen end hv
ad det gør nu. -
Cantargia: Interview med vd Göran Forsberg:https://www.proinvestor.com/index.php?p=debat_1&postid=89287
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
Send flere links....